Clinical trial Recruiting at 1 site Observational Ages 18 to 120

Exploring how brain stimulation affects movement after stroke

Official title: Influence of Brain Oscillation-Dependent TMS on Motor Function

Run by National Institutes of Health Clinical Center (CC) · NCT03288220 · Data updated 2026-11-12

This study tests if a type of brain stimulation can help improve movement in people who have had a stroke and healthy adults by looking at how timing affects the results.

Quick facts

Study typeObservational
Ages18 Years to 120 Years
SexAll
Enrollment114 (estimated)
SponsorNational Institutes of Health Clinical Center (CC)
NIH
Locations1 site (Bethesda, Maryland)
StatusRecruiting
StartedSeptember 11, 2018
Main results expectedMarch 30, 2030
Study endsMarch 30, 2030
Registry record updatedOctober 5, 2026
Trial IDNCT03288220 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults aged 18 and older who have had a stroke at least 6 months ago or healthy volunteers aged 50 and older.

Probably not a fit

Patients who are unable to voluntarily contract muscles in the affected arm or who had a stroke less than 6 months ago may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the effects of transcranial magnetic stimulation (TMS) on motor function in both healthy adults and individuals who have experienced a stroke. Researchers aim to determine how the timing of brain stimulation correlates with brain oscillation phases to improve the consistency of TMS effects. Participants will undergo screening and TMS sessions to measure their brain's response to stimulation. The goal is to enhance rehabilitation strategies for stroke patients by understanding the relationship between brain activity and motor function.

Why it matters

Potential benefit: If successful, this research could lead to more effective rehabilitation techniques for stroke patients, improving their motor function.

How similar studies have gone: While TMS has been studied in various contexts, this specific approach of timing stimulation with brain oscillation phases is novel and has not been extensively tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
* INCLUSION CRITERIA:
* Healthy younger adults:

  * Ages 18 years to less than 50 years. (18 to 49)
  * Willingness/ability to provide informed consent.
  * Ability to induce a motor evoked potential in the muscle target of the upper extremity, as evaluated during the TMS Screening.
* Healthy older adults:

  * Age 50 and over
  * Willingness/ability to provide informed consent.
  * Ability to induce a motor evoked potential in the muscle target of the upper extremity, as evaluated during the TMS Screening.
* Stroke patients:

  * Age 18 and over.
  * Unilateral or bilateral upper limb paresis with the ability to voluntarily contract a finger, hand, wrist, or elbow muscle in the affected arm(s).
  * Stroke onset \> 6 months prior to participation.
  * Intact M1 sufficient to induce motor evoked potentials in the affected upper extremity following ipsilesional TMS, as evaluated during the TMS Screening.
  * Willingness/ability to provide informed consent.

    * If the investigator feels the individual s capacity to provide informed consent is questionable, the NIH Human Subjects Protection Unit (HSPU) will be requested to determine the individual s ability to consent.

EXCLUSION CRITERIA:

* Healthy younger and older adults:

  * Presence of severe neurological or medical disorder (e.g., Parkinson s disease or multiple sclerosis).
  * History of seizures.
  * Chronic use of antipsychotic drugs (e.g., chlorpromazine or clozapine), tri-cyclic or other anti-depressants, benzodiazepines, or prescription stimulants.
  * TMS contraindications, such as:

    * Pacemaker, implanted pump, stimulator, cochlear implant, or metal objects inside the eye or skull.
    * Diagnosed severe hearing loss.
  * Current pregnancy.
  * Staff from our section.
* Stroke patients:

  * Presence of severe neurological or medical disorder, other than stroke (e.g., Parkinson s disease or multiple sclerosis).
  * History of brainstem stroke.
  * History of seizures.
  * Chronic use of antipsychotic drugs (e.g., chlorpromazine or clozapine), benzodiazepines, or prescription stimulants.
  * TMS contraindications, such as:

    * Pacemaker, implanted pump, stimulator, cochlear implant, or metal objects inside

the eye or skull.

---Diagnosed severe hearing loss.

* Current pregnancy.
* Staff from our section.

Where it's running

  • National Institutes of Health Clinical Center
    Bethesda, Maryland, United States
    Recruiting

Study contacts

  • Principal investigator: Leonardo G Cohen, M.D. — National Institute of Neurological Disorders and Stroke (NINDS)
  • Study coordinator: Catherine L Blumhorst, C.R.N.P.
  • Email: cathy.blumhorst@nih.gov
  • Phone: (301) 451-1335

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.